Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)

NCT04321031 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

256

Enrollment

INDUSTRY

Sponsor class

Conditions

Nonalcoholic Fatty Liver Disease
Nonalcoholic Steatohepatitis With Liver Fibrosis

Interventions

DRUG: Placebo
DRUG: PF-06865571
DRUG: PF-05221304

Sponsor

Pfizer